dm+d
412554007
Medicine Compliance Aid Stability
Targaxan/Xifaxanta
Norgine Ltd
Norgine Ltd
Targaxan/Xifaxanta
Tablets 200mg, 550mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Hygroscopic Store in airtight container, protect from light. Maximum 7 days in MCA.
25 October 2022
Lactation Safety Information
No published evidence of safety
Not absorbed from the infant's GI tract
Unlikely to cause adverse effects in the breastfed infant
22 September 2020